INO.com by TIFIN
Sign Up Log In
Welcome back!
Magnifi
Magnifi
  • Stocks & ETFs

    Pulse

    • Stock Market Snapshot

    World Indices

    • Americas
    • Asia/Pacific
    • Europe
    • Middle East/Africa

    U.S. Indices

    • Dow Jones Industrial Average
    • S&P 500

    Exchange Traded Funds (ETFs)

    • ETF Quote Board

    Market Action

    • Extreme Markets
    • Extreme Stock Winners
    • Extreme Stocks Losers
    • Extreme Stocks Under $5
    • Extreme Canadian Stocks
    • Extreme NASDAQ Stocks
    • Extreme NYSE Stocks
    • Recent Splits

    Free Tools & Analysis

    • Top Stocks
    • Top Penny Stocks
    • Top Tech Stocks
    • Top ETFs
    • Stock of the Week
    • Trend Analysis Report
  • Forex

    Realtime Foreign Exchange

    • Dollar Rates
    • Euro Rates
    • Spot Metals
    • Asian Currencies
    • European Currencies
    • World Currencies
    • Cryptocurrencies

    Free Tools & Analysis

    • Top Forex Pairs
  • Resources

    INO Portfolio

    • Fast View
    • Detailed View
    • Login or Create Portfolio

    Drift Trader

    • Learn More
    • Log In

    MarketClub

    • Join Now
    • Log In
    • Trade Triangle Signals
    • Free Trend Analysis

    Free Tools & Analysis

    • Market Commentary
    • Daily Market Breakdown
    • Trend Analysis Report

    Help

    • Email Services
    • About INO
    • Advertising
    • Contact Us
  • AI Investing
  • Blog

HealthEquity - 2021 Second Half Upside

Posted on July 29, 2021 by Noah Kiedrowski

HealthEquity (HQY) was an undervalued and underappreciated stock that was a screaming buy at the sub $50 level back in Q4 of 2020. The stock roared back from those suppressed levels to above $90 in Q1 2021. Since then, HealthEquity has fallen from its 52-week highs of $93 to a current price of ~$79 or about 15% off its highs. The recent weakness presents a great entry point for this healthcare cost containment company.

Considering HealthEquity’s unique position as being distinctly disassociated from drug pricing issues, rising insurance costs, or the pharmaceutical supply chain, this weakness looks appealing. For long-term investors, HealthEquity presents a compelling picture of growth with a large addressable market moving forward.

Total Addressable Market

Over the past 5 years, HealthEquity has delivered and combination of growth, transparency, profitability, and a sustainable business model (Figures 1, 2, and 3). Total accounts across the consumer-directed benefits include HSAs, FSAs, HRAs, CORBA, Commuter, and others continue to expand while opening growth verticals within these accounts. At maturity, the total addressable market is estimated to be 50-60 million HSAs with $600 billion - $1 trillion in assets. HealthEquity is in the early innings of market share as it continues to grow into this space.

HealthEquity
Figure 1 – HealthEquity demonstrating their compelling long-term growth strategy

HealthEquity
Figure 2 – High-level overview of the newly combined HealthEquity company branching out into all segments of consumer-directed benefits

HealthEquity
Figure 3 – Total addressable market for consumer-directed benefits

Post-Pandemic HSA Awareness

The COVID-19 pandemic will likely bring more attention to the Health Savings Account (HSA) space and may drive demand from more companies and consumers alike. The Health Savings account serves as a win-win for companies and consumers. This is an effective way to contain healthcare costs while allowing funds to accumulate for potential future medical expenses. This space has already been under a secular growth trend, and this pandemic may accelerate the growth of these accounts as awareness spreads. Over the long term, this trend toward consumer-driven healthcare (i.e., channeling funds into HSAs) is here to stay.

Moat and Business Model

HealthEquity (HQY) has a unique business model that serves as an intermediary servicing the secular growth HSA space that is largely independent of legislative actions, drug pricing, rising insurance costs while not playing any role in the pharmaceutical supply chain that spans from health insurers to end-user pharmacies. The company simply manages funds allocated for medical, dental, and vision expenses that are deducted on a pre-tax basis and deposited into a dedicated HSA account. The HSA space has grown in popularity as corporate adoption has allowed access to these plans in conjunction with consumer awareness. HealthEquity is an intermediary that connects health and wealth to consumers of healthcare.

Diversifying Revenue Streams

HealthEquity made a bold move to acquire WageWorks for approximately $2 billion in an all-cash deal. This acquisition has expanded HealthEquity’s moat in the HSA space while providing new revenue verticals in complementary product offerings. This move is already expanding HealthEquity’s total addressable market as Consumer-Directed Benefits (CDBs) via pre-tax spending accounts such as additional Health Savings Accounts (HSAs), health and dependent care Flexible Spending Accounts (FSAs), health reimbursement accounts (HRA), Commuter Benefit Services, wellness programs, COBRA and other employee benefits are absorbed into its product offerings. In addition, this acquisition provides access to a larger client base and access to health brokers that will help drive HealthEquity’s penetration over the long term. The combination of WageWorks’ leading consumer-directed benefits with HealthEquity’s HSA platform is highly synergistic and will drive growth while expanding the total addressable market in years to come.

Summary

HealthEquity (HQY) has continued its path of accelerating revenue, cash flow, and income growth across all segments of its business in the backdrop of an HSA secular growth market. Its WageWorks acquisition further bolstered this by augmenting its core competencies in the Health Savings Account space while accessing other revenue verticals in the Consumer Directed-Benefits space. HealthEquity continues to post strong growth as it expands the number of accounts, manages more custodial assets, expands gross margins, and more accounts transitioning into investment vehicles. HealthEquity is uniquely positioned as HSAs become an invaluable option for consumers to contain medical costs and control healthcare spending. Best of all, the company’s business model is such that it stands as an intermediary, servicing the secular growth HSA space that is largely independent of legislative actions, drug pricing, rising insurance costs while not playing any role in the pharmaceutical supply chain from health insurers to end-user pharmacies. As a result, the WageWorks acquisition has expanded HealthEquity’s moat while providing additional long-term revenue sources for durable growth.

Noah Kiedrowski
INO.com Contributor

Disclosure: The author holds shares in AAPL, AMZN, DIA, GOOGL, JPM, MSFT, QQQ, SPY and USO. He may engage in options trading in any of the underlying securities. The author has no business relationship with any companies mentioned in this article. He is not a professional financial advisor or tax professional. This article reflects his own opinions. This article is not intended to be a recommendation to buy or sell any stock or ETF mentioned. Kiedrowski is an individual investor who analyzes investment strategies and disseminates analyses. Kiedrowski encourages all investors to conduct their own research and due diligence prior to investing. Please feel free to comment and provide feedback; the author values all responses. The author is the founder of www.stockoptionsdad.com where options are a bet on where stocks won’t go, not where they will. Where high probability options trading for consistent income and risk mitigation thrives in both bull and bear markets. For more engaging, short duration options based content, visit stockoptionsdad’s YouTube channel.

Posted in INO.com ContributorsTagged Affordable Health Care Act Flexible Savings Account (FSA) Health Plans Health Savings Account (HSA) HealthEquity Inc. (NASDAQ:HQY) High Deductible Health Plans (HDHPs) HSA Assets Medical Coverage Medical Plan Premiums noah kiedrowski Retirement Planning Tax Break traditional IRA WageWorks

Post navigation

ESG Investing Is Costing You Money
Earnings Calendar for August 2021

Search Trader’s Blog

Magnifi Personal

Build a long-term portfolio in minutes. Try Magnifi Personal - Free Trial.

Recent Posts

  • EV Supply Chain Play: Why Solid Power (SLDP) Could Be a Hidden Gem in Battery Tech
  • Streaming Wars Continue: Why fuboTV (FUBO) Could Surprise Investors
  • Cloud Computing Boom: Why DigitalOcean (DOCN) Could Be an Underrated Growth Stock
  • AI in Healthcare: Why Tempus AI (TEM) Could Be a Game-Changer in Precision Medicine
  • Rising Cyber Threats: Why SentinelOne (S) Could Be a Breakout Cybersecurity Stock

Market Reports

  • Gold
  • S&P500
  • Dow
  • Nasdaq
  • Crude Oil

Trader Comments

  • Girraj Sharan Bansal on Copper's Role in the Clean Energy Boom: Stocks to Watch
  • Martin on The Future of NVIDIA: Post-Split Valuation and Growth Projections
  • Pratibha on DOGE's Bullish Signal Amidst Crypto Market Volatility
  • Pratibha on DOGE's Bullish Signal Amidst Crypto Market Volatility
  • William s Brown on Is Boeing (BA) a Recovery Play? Evaluating Upside Potential and Risks

Categories

  • General
  • INO Cares
  • INO.com Contributors
  • MarketClub Options
  • MarketClub Techniques, Tips & Talk
  • Member Success Stories
  • Trading Videos

Blogroll

  • Add Your Blog Here
  • Cannabis Stock Trades
  • Crude Oil Trader
  • Drift Trader
  • ETF Daily News
  • Learn Options Trading
  • Online Stock Trading Guide
  • Options Trading Mastery
  • Stock Gumshoe
  • Traders Day Trading
  • TradeThatSwing
  • VantagePoint Trading Software
Find INO.com on Facebook Follow MarketClub on Twitter Find MarketClub on YouTube Download on the App Store Get It On Google Play
  • Pulse
  • Markets
  • MarketClub
  • Blog
  • Advertising
  • Help
  • Contact Us
  • Usage Agreement
  • Privacy Policy

© Copyright Magnifi Communities. All Rights Reserved.

INO.com, a division of TIFIN Group LLC, is affiliated with Magnifi via common ownership. Affiliates of Magnifi will receive cash compensation for referrals of clients who open accounts with Magnifi. Due to this compensation, a conflict of interest exists since INO has an incentive to recommend Magnifi LLC.

Magnifi LLC does not charge advisory fees or transaction fees for non-managed accounts. Clients who elect to have Magnifi LLC manage all or a portion of their account will be charged an advisory fee. Please see Magnifi’s Form ADV for additional information about fees and charges that may apply. Magnifi LLC receives compensation from product sponsors related to recommendations. Other fees and charges may apply.

Do Not Sell My Information

×

It’s not goodbye, it’s hello Magnifi!

You are now leaving a Magnifi Communities’ website and are going to a website that is not operated by Magnifi Communities. This website is operated by Magnifi LLC, an SEC registered investment adviser affiliated with Magnifi Communities.

Magnifi Communities does not endorse this website, its sponsor, or any of the policies, activities, products, or services offered on the site. We are not responsible for the content or availability of linked site.

Take Me To Magnifi